NLRP3 may be not the direct binding partner of the compounds, which may bind to various upstream regulators of NLRP3 to regulate the activity of the inflammasome, and, therefore, affect the progression of arthritis. This evidence concerns the gene NLRP3 and arthritic joint disease.